Englewood Lab Inc (950140) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Englewood Lab Inc (950140) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.76 Billion ≈ $4.58 Million USD) by net assets (₩154.89 Billion ≈ $104.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Englewood Lab Inc (950140) market capitalisation for the company's overall valuation and market capitalisation.
Englewood Lab Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Englewood Lab Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Englewood Lab Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Englewood Lab Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of Englewood Lab Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tera Autotech
TWO:6234
|
0.013x |
|
China Silver Group Limited
F:2CS
|
0.015x |
|
Pollux Investasi Internasional Tbk PT
JK:POLI
|
0.013x |
|
Calitech Co Ltd
TWO:6532
|
0.019x |
|
QRF SCA
BR:QRF
|
-0.001x |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
-0.074x |
|
Payton -L
TA:PAYT
|
0.010x |
|
Affluent Medical SAS
PA:AFME
|
-0.319x |
Annual Cash Flow Conversion Efficiency for Englewood Lab Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Englewood Lab Inc from 2015 to 2024. View 950140 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩97.89 Million ≈ $66.34K |
₩9.47 Million ≈ $6.42K |
0.097x | -46.14% |
| 2023-12-31 | ₩89.12 Million ≈ $60.40K |
₩16.01 Million ≈ $10.85K |
0.180x | -99.86% |
| 2022-12-31 | ₩73.41 Million ≈ $49.75K |
₩9.56 Billion ≈ $6.48 Million |
130.256x | +229.58% |
| 2021-12-31 | ₩68.28 Million ≈ $46.28K |
₩-6.86 Billion ≈ $-4.65 Million |
-100.526x | -176.80% |
| 2020-12-31 | ₩55.76 Million ≈ $37.79K |
₩7.30 Billion ≈ $4.95 Million |
130.892x | -42.97% |
| 2019-12-31 | ₩52.79 Million ≈ $35.78K |
₩12.12 Billion ≈ $8.21 Million |
229.494x | +224.24% |
| 2018-12-31 | ₩50.72 Million ≈ $34.37K |
₩-9.37 Billion ≈ $-6.35 Million |
-184.721x | -15.82% |
| 2017-12-31 | ₩56.31 Million ≈ $38.16K |
₩-8.98 Billion ≈ $-6.09 Million |
-159.487x | -340171.13% |
| 2016-12-31 | ₩61.90 Million ≈ $41.95K |
₩-2.90 Million ≈ $-1.97K |
-0.047x | -10.74% |
| 2015-12-31 | ₩26.65 Billion ≈ $18.06 Million |
₩-1.13 Billion ≈ $-764.48K |
-0.042x | -- |
About Englewood Lab Inc
Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; a… Read more